SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chiron -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (1328)12/8/2004 11:01:50 AM
From: Robert Douglas  Respond to of 1352
 
Currently analysts from brokerage firms are not going to take any risks on their recommendations. This will change at the next market top but for now 16 of 18 firms have Chiron at a "Hold" or below.



To: fred hayes who wrote (1328)12/8/2004 5:57:36 PM
From: mopgcw  Respond to of 1352
 
Your thought and my initial guess were the same, that it was miss this season only, the stock would be a buy here. if they miss next season too because of the issues in the piper report, personally i would look for a bigger margin of safety. seems to be shaping up that way, unless there is other info out there. what concerns me most about the piper report are the comments on posture and attitude. reads as though they still dont know what the problem is...ouch.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News